{"id":31121,"date":"2010-09-23T14:44:18","date_gmt":"2010-09-23T19:44:18","guid":{"rendered":"https:\/\/www.dietsinreview.com\/diet_column\/?p=31121"},"modified":"2010-09-23T14:46:01","modified_gmt":"2010-09-23T19:46:01","slug":"avandia-heavily-restricted-by-fda","status":"publish","type":"post","link":"https:\/\/dietsinreview.com\/diet_column\/09\/avandia-heavily-restricted-by-fda\/","title":{"rendered":"Avandia Heavily Restricted by FDA"},"content":{"rendered":"

\"Diabetes<\/a>In July, it looked like the Food and Drug Administration was going to be Avandia’s saving grace, when a 33-person panel voted to allow the diabetes<\/a> medication to stay on the market. Many felt the decision would stave off litigation against its manufacturer, GlaxoSmithKline. But today, the agency announced a heavy restriction Avandia, although they will not be pulling the drug off the U.S. market. The European Medicines Agency, FDA’s counterpart in the EU, has decided to ban the drug.<\/p>\n

Avandia has been associated with an increased risk of heart problems, including heart attacks<\/a> and strokes. The new FDA regulations will now restrict the use of Avandia<\/a> to only those suffering from type 2 diabetes who cannot achieve glycemic control on other medications. The FDA is further requiring GlaxoSmithKline to pay for a new independent study that will compare Avandia with Actos, the competing diabetes drug. They are also asking the manufacturer to tightly regulate the future distribution of Avandia.<\/p>\n

GlaxoSmithKline continues to stand behind its product. In a statement, they wrote that “The company continues to believe that Avandia is an important treatment for patients with type 2 diabetes<\/a> and is now working with the FDA and EMA to implement the required actions.”<\/p>\n

Sources: fda.gov<\/a> and cnn.com<\/a><\/p>\n

Also Read:<\/strong><\/p>\n

Avandia Saved by FDA<\/a><\/strong><\/p>\n

Diabetic Living Diet<\/a><\/strong><\/p>\n

Five Easy Food Swaps to Prevent Diabetes<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

In July, it looked like the Food and Drug Administration was going to be Avandia’s saving grace, when a 33-person panel voted to allow the diabetes medication to stay on the market. Many felt the decision would stave off litigation … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":26,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[350],"tags":[4433,565,99,784,1359],"class_list":["post-31121","post","type-post","status-publish","format-standard","hentry","category-diabetes","tag-avandia","tag-drugs","tag-fda","tag-heart-attack","tag-type-2-diabetes"],"acf":[],"_links":{"self":[{"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/posts\/31121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/comments?post=31121"}],"version-history":[{"count":4,"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/posts\/31121\/revisions"}],"predecessor-version":[{"id":31127,"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/posts\/31121\/revisions\/31127"}],"wp:attachment":[{"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/media?parent=31121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/categories?post=31121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dietsinreview.com\/diet_column\/wp-json\/wp\/v2\/tags?post=31121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}